Retatrutide, CagriSema and Emerging Treatments Retatrutide, CagriSema, survodutide, MariTide, VK2735, eloralintide and other next-generation treatments remain investigational for routine obesity care as of July 2026
Thc y tc mng chc khe, b sung m cn thit cho da kh
Peer review Peer review information Nature Reviews Neurology thanks Hlio Teive, Ludger Schls and the other, anonymous, reviewer(s) for their contribution to the peer review of this work
But lets not skip the boring stuffbecause the benefits go beyond the gym
Never just a number You are seen, remembered, and supported as a person not a chart number
Before-and-after photos are useful when weighing your weight loss options, but you can also use our patient reviews to enhance your decision-making